JP2004513150A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004513150A5 JP2004513150A5 JP2002540749A JP2002540749A JP2004513150A5 JP 2004513150 A5 JP2004513150 A5 JP 2004513150A5 JP 2002540749 A JP2002540749 A JP 2002540749A JP 2002540749 A JP2002540749 A JP 2002540749A JP 2004513150 A5 JP2004513150 A5 JP 2004513150A5
- Authority
- JP
- Japan
- Prior art keywords
- factor xiii
- therapeutic agent
- hemophilia
- administered
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010071289 Factor XIII Proteins 0.000 claims 7
- 229940012444 factor xiii Drugs 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 5
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 208000031220 Hemophilia Diseases 0.000 claims 3
- 208000009292 Hemophilia A Diseases 0.000 claims 3
- 102100022641 Coagulation factor IX Human genes 0.000 claims 1
- 108010076282 Factor IX Proteins 0.000 claims 1
- 229960004222 factor ix Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24736200P | 2000-11-10 | 2000-11-10 | |
| PCT/US2001/047144 WO2002038167A2 (en) | 2000-11-10 | 2001-11-08 | Use of factor xiii for treating hemophilia b |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004513150A JP2004513150A (ja) | 2004-04-30 |
| JP2004513150A5 true JP2004513150A5 (https=) | 2005-07-21 |
Family
ID=22934628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002540749A Pending JP2004513150A (ja) | 2000-11-10 | 2001-11-08 | Ｂ型血友病の治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1351706B1 (https=) |
| JP (1) | JP2004513150A (https=) |
| AT (1) | ATE367824T1 (https=) |
| AU (1) | AU2002226004A1 (https=) |
| CA (1) | CA2429018A1 (https=) |
| DE (1) | DE60129599T2 (https=) |
| ES (1) | ES2288524T3 (https=) |
| WO (1) | WO2002038167A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080176789A1 (en) | 2004-08-27 | 2008-07-24 | Novc Nordisk Healthcare A/G | Purification of Factor Xlll Polypeptides From Biological Materials |
| ES2378777T3 (es) | 2004-11-23 | 2012-04-17 | Zymogenetics, Inc. | Purificación del factor XIII humano recombinante |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989001512A1 (en) * | 1987-08-17 | 1989-02-23 | The Liposome Company, Inc. | A sponge enzyme having transglutaminase-like activity |
| CA2406583A1 (en) * | 2000-05-10 | 2001-11-15 | Novo Nordisk A/S | Pharmaceutical composition comprising a factor viia and a factor xiii |
-
2001
- 2001-11-08 JP JP2002540749A patent/JP2004513150A/ja active Pending
- 2001-11-08 AT AT01993470T patent/ATE367824T1/de not_active IP Right Cessation
- 2001-11-08 CA CA002429018A patent/CA2429018A1/en not_active Abandoned
- 2001-11-08 WO PCT/US2001/047144 patent/WO2002038167A2/en not_active Ceased
- 2001-11-08 ES ES01993470T patent/ES2288524T3/es not_active Expired - Lifetime
- 2001-11-08 DE DE60129599T patent/DE60129599T2/de not_active Expired - Lifetime
- 2001-11-08 EP EP01993470A patent/EP1351706B1/en not_active Expired - Lifetime
- 2001-11-08 AU AU2002226004A patent/AU2002226004A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006501240A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2014530874A5 (https=) | ||
| MY129512A (en) | Novel medicament compositions, based on tiotropium bromide and salmeterol | |
| JP2012532874A5 (https=) | ||
| JP2007513993A5 (https=) | ||
| JP2009500443A5 (https=) | ||
| GEP20063799B (en) | Tropane derivatives useful in therapy | |
| ATE444067T1 (de) | Neue arzneimittelkompositionen auf der basis von tiotropiumsalzen und ciclesonide | |
| WO2003009838A1 (en) | Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus | |
| JP2002528502A5 (https=) | ||
| JP2015524444A5 (https=) | ||
| JP2017506624A5 (https=) | ||
| JP2005507892A5 (https=) | ||
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| JP2005508963A5 (https=) | ||
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| JP2003526626A5 (https=) | ||
| JP2005500277A5 (https=) | ||
| JP2002540148A5 (https=) | ||
| JP2003528919A5 (https=) | ||
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| JP2003522147A5 (https=) | ||
| JP2009516719A5 (https=) |